Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

33.10
Delayed Data
As of 3:59pm ET
 +0.05 / +0.15%
Today’s Change
29.95
Today|||52-Week Range
58.95
+2.48%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues85.6M197.7M249.0M276.4M
 
 
 
 
 
Cost of Goods Sold49.0M67.4M60.4M97.2M
 
 
 
 
 
Depreciation And Amortization5.7M10.0M11.5M12.9M
 
 
 
 
 
 
Operating ExpensesGross Income30.8M120.2M177.2M166.3M
 
 
 
 
 
General Expenses84.1M125.4M167.7M191.2M
 
 
 
 
 
Research And Development21.6M18.7M28.7M45.7M
 
 
 
 
 
Total Operating Expenses138.8M202.8M239.5M301.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-53.3M-5.2M9.5M-24.9M
 
 
 
 
 
Extraordinary Charge-3.4M0.00-52.0K-7.1M
 
 
 
 
Interest Expense On Debt9.0M9.0M8.6M8.6M
 
 
 
 
 
Other Expenses-47.0K-159.0K-165.0K-82.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-64.4M-13.5M2.1M-37.8M
 
 
 
 
 
Income Taxes-442.0K-173.0K-264.0K-105.0K
 
 
 
 
 
Net Income-63.9M-13.7M1.9M-37.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS33.2M35.3M36.5M37.2M
 
 
 
 
 
Shares To Calculate EPS Diluted33.2M35.3M41.3M37.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.93-$0.39$0.04-$1.02
 
 
 
 
 
EPS Diluted-$1.93-$0.39$0.04-$1.02